Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF.
about
Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation.Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas.An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors.Variant rs1801157 in the 3'UTR of SDF-1ß does not explain variability of healthy-donor G-CSF responsivenessESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients.Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma.Effect of prior chemotherapy on hematopoietic stem cell mobilization.A BCNU-containing Regimen, Mini-BEAM, with GM-CSF is a Safe and Effective Mobilizing Regimen Pre-stem Cell Transplantation in Lymphoma Patients.ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients.A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts.Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization.
P2860
Q33335451-B9A578B9-D4A8-4025-B8D3-1CBC29AA234CQ33389752-E495DE58-08EB-4DF7-ADC8-CAFD6D35EAABQ35110151-7BD8E8DC-74C8-4EB1-A95C-9BCBABFC3CB7Q35213695-0B67C787-51F4-49D9-B632-24B8A21D2966Q36621049-2CF8A202-4E86-417A-8B98-CB7F67FC6F89Q41969982-658E953E-FC89-4FC9-8354-8E3555BAC59FQ44123961-EE819453-DCAD-4770-8E5A-CE5D5CA11CCDQ44788991-F751D8B5-0963-45D9-B869-0AAEDFFD8575Q46009562-E1EC949A-4191-4151-980E-3B3296F89912Q46885001-06D9CFA5-2E0C-4480-940E-6542700EA842Q52964889-BCD4FA2E-151A-475D-BA11-7055F5C09038Q53629198-D05AA299-40AA-4C4B-8CAF-8DD3B17596B9
P2860
Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Predictors for optimal mobiliz ...... se cyclophosphamide and G-CSF.
@en
type
label
Predictors for optimal mobiliz ...... se cyclophosphamide and G-CSF.
@en
prefLabel
Predictors for optimal mobiliz ...... se cyclophosphamide and G-CSF.
@en
P2093
P1433
P1476
Predictors for optimal mobiliz ...... se cyclophosphamide and G-CSF.
@en
P2093
P356
10.1016/S0145-2126(96)00059-8
P577
1997-01-01T00:00:00Z